Treatment Options for Hodgkin Lymphoma in Children

Treatment Goals

Hodgkin lymphoma is a type of cancer that can affect children and adolescents. It occurs in the lymph system, which is a part of the immune system and includes organs, lymph nodes, and bone marrow.

The objective of treating Hodgkin Lymphoma in children is to achieve a cure, slow the progression of the disease, or control symptoms. The specific treatment approach depends on various factors such as the child's age, the extent of the lymphoma, and other individual factors.

It's important to remember that each child's case is unique, and treatment decisions should be made in consultation with their healthcare team.

Treatment Options

When it comes to treating Hodgkin Lymphoma in children, the recommended initial treatment depends on the risk category of the disease. Here are the potential treatments for each risk category:

  • Surgery: In some cases, complete surgical resection may be curative and eliminate the need for cytotoxic therapy. This option is considered for localized nodular lymphocyte-predominant Hodgkin Lymphoma. For nodular lymphocyte-predominant Hodgkin Lymphoma in children, surgery may be needed to remove the affected lymph node. In some cases, chemotherapy may not be necessary.
  • Chemotherapy: For classic Hodgkin Lymphoma in children, doctors often use a combination of chemotherapy and low-dose radiation therapy. The specific treatments are adjusted based on the child's age, the extent of the lymphoma, and other factors.
    • Children's bodies tend to tolerate chemotherapy better than adults in the short term. However, they may require lifelong monitoring due to potential side effects that can occur years later.
  • Stem Cells: If the lymphoma does not respond to initial treatment, a doctor may recommend a stem cell transplant or treatment with an immunotherapy drug.
  • Clinical trials are also available as an option for treatment. These trials can provide access to new and promising treatments.

Here are the potential treatments for each risk category:

Low-Risk Classic Childhood Hodgkin Lymphoma:

  • Combination chemotherapy: This treatment involves using a combination of different chemotherapy drugs to kill cancer cells. Chemotherapy can be given orally (through pills) or intravenously (through a vein). The goal of chemotherapy is to destroy cancer cells and prevent them from spreading.
  • Radiation therapy: In some cases, radiation therapy may also be used. This treatment uses high-energy beams to target and destroy cancer cells. It is often used in specific areas where the cancer is located.

Intermediate-Risk Classic Childhood Hodgkin Lymphoma:

  • Combination chemotherapy: Similar to low-risk Hodgkin lymphoma, combination chemotherapy is the main treatment for intermediate-risk cases. It aims to kill cancer cells and stop them from spreading.
  • Radiation therapy: In certain situations, radiation therapy may be used alongside chemotherapy to target specific areas affected by the cancer.

High-Risk Classic Childhood Hodgkin Lymphoma:

  • Higher-dose combination chemotherapy: High-risk cases require more aggressive treatment with higher doses of chemotherapy drugs. The goal is to kill as many cancer cells as possible.
  • Combination chemotherapy with targeted therapy or immunotherapy: In some cases, targeted therapy (using drugs like brentuximab) or immunotherapy (using drugs like nivolumab) may be added to the standard chemotherapy regimen. These treatments specifically target cancer cells and help boost the immune system's ability to fight the disease.
  • Radiation therapy: Similar to other risk categories, radiation therapy may also be used if needed.

Refractory or Recurrent Hodgkin Lymphoma in Children and Adolescents:

For children and adolescents with refractory or recurrent Hodgkin lymphoma (when the cancer does not respond to initial treatment), several treatment options exist:

  • Chemotherapy and targeted therapy: This combination involves using chemotherapy drugs along with targeted therapy drugs that specifically attack cancer cells.
  • Checkpoint inhibitor therapy: Checkpoint inhibitors are a type of immunotherapy that helps stimulate the immune system to recognize and attack cancer cells.
  • Chemotherapy followed by autologous hematopoietic stem cell transplant (HSCT): This treatment involves high-dose chemotherapy followed by a stem cell transplant using the child's own stem cells.
  • Chemotherapy followed by allogeneic HSCT: Similar to autologous HSCT, this treatment uses high-dose chemotherapy followed by a stem cell transplant using stem cells from a donor.
  • Involved-site radiation therapy (ISRT): Radiation therapy may be used in specific areas where the cancer has recurred or is resistant to other treatments.

It's important to note that these recommendations are based on medical guidelines and research. Each child's case is unique, so it's crucial for parents and caregivers to consult their child's healthcare team for personalized advice. They will consider various factors such as the child's age, overall health, and specific characteristics of the disease when determining the best course of treatment.